Developing new methods for the treatment and detection of diabetic retinopathy.

At i-RNA, our vision is your vision.

Our Vision:

A better world when it is seen better by everyone.

globally live with diabetes, with 10+ million new cases anually.

Most patients with diabetes are affected by diabetic retinopathy.

97% of type 1 diabetic patients and 60% of type 2 diabetic patients have diabetic retinopathy.

leading cause of blindness in working age adults worldwide.

Scroll to learn about our company’s journey.

YEAR

Report of Invention

First US Provisional Filing

YEAR

Second provisional licensing application

YEAR

First PCT Filing

Winning Western Innovation Fund

YEAR

i-RNA formed